David Enloe, Societal CDMO CEO
November 9, 2023 06:18 AM EST
Manufacturing

So­ci­etal CD­MO trims pro­ject­ed 2023 sales rev­enue de­spite third-quar­ter earn­ings bump

Anna Brown

News Reporter

So­ci­etal CD­MO is cut­ting its 2023 rev­enue fore­cast to $92 mil­lion to $94 mil­lion — down from the $94 mil­lion to $100 mil­lion it pre­dict­ed ear­li­er …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Bris­tol My­ers CEO sig­nals deal­mak­ing will be a top pri­or­i­ty in 2025

Drug­mak­ers see a sub­stan­tial, but man­age­able, hit to busi­ness from tar­iffs. But the worst may lie ahead

Roche CEO warns that tar­iffs could im­pact deal­mak­ing

Ver­san­t's lat­est biotech fo­cus­es on in­flam­ma­to­ry dis­eases

Roche takes steps to pro­tect it­self from tar­iffs, while Sanofi hangs back

sponsored

AD­STI­LADRIN® (nad­o­fara­gene fi­rade­n­ovec-vncg) – A Grow­ing Body of Clin­i­cal Da­ta and Re­al-World Ev­i­dence

A service from the Financial Times